Sanofi Must Set Record Straight on Rival Flu Shot Under EU Antitrust Deal
Sanofi settles EU antitrust probe over rival flu vaccine Fluad, agreeing to binding promotional rules through 2030.
Share
Why It Matters
Sanofi agreed to follow new rules about how it advertises its flu shot. This means the company must play fair and not block competitors from selling their own flu shots.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.